Barry Teater

Guest Column | Good R&D leadership is knowing when to keep investing in a development program, when to change course, and when to return to base, writes David Adler, M.D./Ph.D., MBA. Guest Column | Precision oncology only works when biomarker testing helps identify the right patients at scale before launch, explains Boehringer Ingelheim’s Vicky Brown.

RESEARCH TRIANGLE PARK – Millions of Americans are at risk for anaphylaxis, a severe allergic reaction to medicines, foods, bee stings, insect bites, dust, latex or other substances. And up to 25% of those at risk have not been diagnosed. People who have an anaphylactic reaction require a fast emergency treatment to reverse potentially life-threatening symptoms such as difficulty breathing, swelling of the throat and tongue, rash, nausea and shock.